These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 11090080

  • 1. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
    Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A.
    Blood; 2000 Dec 01; 96(12):3932-8. PubMed ID: 11090080
    [Abstract] [Full Text] [Related]

  • 2. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.
    Parker JE, Fishlock KL, Mijovic A, Czepulkowski B, Pagliuca A, Mufti GJ.
    Br J Haematol; 1998 Dec 01; 103(4):1075-82. PubMed ID: 9886323
    [Abstract] [Full Text] [Related]

  • 3. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z, Xie J.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun 01; 11(3):274-7. PubMed ID: 12844412
    [Abstract] [Full Text] [Related]

  • 4. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
    Boudard D, Vasselon C, Berthéas MF, Jaubert J, Mounier C, Reynaud J, Viallet A, Chautard S, Guyotat D, Campos L.
    Am J Hematol; 2002 Jun 01; 70(2):115-25. PubMed ID: 12111784
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M.
    Br J Haematol; 2000 Sep 01; 110(3):584-90. PubMed ID: 10997968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H, Tsushima Y, Nagai K, Yagihashi S.
    Acta Haematol; 2000 Sep 01; 102(3):115-23. PubMed ID: 10692673
    [Abstract] [Full Text] [Related]

  • 10. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO, Jilani I, Estey E, Giles F, Kantarjian H, Freireich E, Albitar M.
    Leukemia; 2002 Nov 01; 16(11):2249-52. PubMed ID: 12399969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K, Karube K, Shimazaki K, Kamma H, Suzumiya J, Hamasaki M, Kikuchi M.
    Leuk Lymphoma; 2003 Aug 01; 44(8):1339-46. PubMed ID: 12952227
    [Abstract] [Full Text] [Related]

  • 13. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.
    Pathologe; 2000 Jan 01; 21(1):1-15. PubMed ID: 10663664
    [Abstract] [Full Text] [Related]

  • 14. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S, Kurata M, Abe S, Onishi I, Kirimura S, Nashimoto M, Murayama T, Hidaka M, Kitagawa M.
    Lab Invest; 2014 Nov 01; 94(11):1212-23. PubMed ID: 25199050
    [Abstract] [Full Text] [Related]

  • 15. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis.
    Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H, Yasunaga S, Takihara Y, Kimura A.
    Blood; 2006 Jan 01; 107(1):305-8. PubMed ID: 16160010
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
    Rajapaksa R, Ginzton N, Rott LS, Greenberg PL.
    Blood; 1996 Dec 01; 88(11):4275-87. PubMed ID: 8943864
    [Abstract] [Full Text] [Related]

  • 18. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
    Berger G, Hunault-Berger M, Rachieru P, Fontenay-Roupie M, Baranger L, Ifrah N, Zandecki M.
    Hematol J; 2001 Dec 01; 2(2):87-96. PubMed ID: 11424000
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression.
    Davis RE, Greenberg PL.
    Leuk Res; 1998 Sep 01; 22(9):767-77. PubMed ID: 9716007
    [Abstract] [Full Text] [Related]

  • 20. Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes.
    Varma N, Varma S.
    Indian J Pathol Microbiol; 2008 Sep 01; 51(1):97-101. PubMed ID: 18417875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.